NAFLD and renal function in children: is there a genetic link?

Anna Di Sessa1, Stefano Guarino1, Antonio Paride Passaro1

  • 1Department of Woman Child and of General and Specialized Surgery, Università Degli Studi Della Campania "Luigi Vanvitelli", Napoli, Italy.

Insights

Genetic factors may link childhood Nonalcoholic Fatty Liver Disease (NAFLD) and chronic kidney disease (CKD). Understanding this connection could help manage cardiometabolic risk in children with NAFLD.

Area of Science:

  • Pediatric Nephrology
  • Hepatology
  • Genetics

Background:

  • Nonalcoholic Fatty Liver Disease (NAFLD) and chronic kidney disease (CKD) share a cardiometabolic burden.
  • Genetic polymorphisms in NAFLD, such as PNPLA3 and TM6SF2, are suspected to influence renal function.
  • The exact shared pathogenic mechanisms between NAFLD and CKD remain unclear.

Purpose of the Study:

  • To review the potential genetic link between NAFLD and CKD specifically in the pediatric population.
  • To synthesize existing evidence on the association between NAFLD genetic factors and kidney function in children.
  • To address the existing disputes regarding this association in childhood.

Main Methods:

  • Comprehensive literature review focusing on genetic associations between NAFLD and CKD in children.
  • Analysis of studies examining major NAFLD-associated gene polymorphisms (PNPLA3, TM6SF2, HSD17B13, MBOAT7-TMC4) and their impact on renal function.
  • Synthesis of adult and pediatric data to evaluate the genetic link in childhood.

Main Results:

  • Adult data strongly support an association between NAFLD and CKD.
  • Evidence for a genetic link in pediatric populations is emerging but debated.
  • Specific NAFLD gene variants are hypothesized to play a role in the development of CKD in children.

Conclusions:

  • A potential genetic link between NAFLD and CKD in children is an important area of research.
  • Further investigation is needed to elucidate the precise genetic mechanisms involved.
  • Identifying these genetic links could lead to improved strategies for managing cardiometabolic risk in affected children.

Related Concept Videos

Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
241
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
51
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
50
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
74
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
242
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
70